Clinical Trial Update: Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating oral insulin to prevent Type 1 diabetes in relatives at risk; completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Oral insulin (insulin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2020-02-18